American Portfolios Advisors Bicycle Therapeutics PLC Transaction History

American Portfolios Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Mar 21, 2023	BUY	$40.12 - $59.5 $3,851 - $5,712	96 New	96 $4.21 Million
Q4 2021 Mar 21, 2023	BUY	$41.7 - $61.14 $4,753 - $6,969	114 New	114 $6.94 Million
Q3 2021 Mar 22, 2023	BUY	$27.95 - $44.24 $3,186 - $5,043	114 New	114 $4.74 Million
Q2 2021 Mar 22, 2023	BUY	$27.0 - $32.28 $3,078 - $3,679	114 New	114 $3.46 Million

30.6M

85.5K

11.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $600M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.